| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Original Article |
Brigham & Women's Hospital, Harvard Medical School, Boston, MA
* Corresponding author; email: mdicarli{at}partners.org
Background—Coronary artery disease is the main cause of mortality and morbidity in patients with impaired renal function. The aim of this study is to evaluate the prognostic implications of single photon emission computed tomography myocardial perfusion imaging (SPECT-MPI) in patients with impaired renal function.
Methods and Results—We included 7348 consecutive patients (mean age 64 ± 13 years, 51% males) referred for SPECT-MPI between 3/02 and 10/06. Renal function was estimated using the estimated glomerular filtration rate (GFR) formula. Patients were followed up for the incidence of all cause mortality. Patients with decreased GFR were more often older with higher prevalence of conventional risk factors (p<.001). After a median follow-up 2.6 years (25th - 75th percentile 1.5 - 3.7), 693(9.4%) patients died. The risk of death increased with worsening kidney function. At each stage of impaired renal function, patients with abnormal SPECT-MPI had increased hazard of adverse events (p<.0001). Using Cox proportional hazard analysis, the magnitude of total perfusion deficit and ischemia on MPI were associated with worse outcome after adjusting for confounding variables including GFR and ejection fraction.
Conclusions—SPECT-MPI adds modest incremental prognostic information to identify patients at higher relative risk of death across a wide spectrum of renal function.
Key Words: coronary disease imaging kidney mortality nuclear medicine scintigraphy end stage renal disease renal insufficiency single-photon emission computed tomography myocardial perfusion imaging
|
Home | Subscriptions | Archives | Feedback | Authors | Help | Circulation Journals Home | AHA Journals Home | Search Copyright © 2009 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |